🔎 Trials Near Me

Utama › Kanser Paru-paru Bukan Sel Kecil › Pennsylvania › Allentown

Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Allentown, PA

14 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Allentown (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mengambil pesertaFasa 3
  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem · 6 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT04267848

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Mengambil pesertaFasa 3
  • St. Lukes Hospital and Health Network ( Site 0186), Bethlehem · 6 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06623422

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Mengambil pesertaFasa 3
  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem · 6 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06498635

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Mengambil pesertaFasa 3
  • Alliance Cancer Specialists, Sellersville · 20 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06765109

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Mengambil pesertaFasa 3
  • Alliance Cancer Specialists, PC, Sellersville · 20 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07144280

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Research Site, Fountain Hill · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06868277

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Mengambil pesertaFasa 2
  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem · 6 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT03191149

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

Mengambil pesertaFasa 3
  • St Luke's University Health Network ( Site 0017), Bethlehem · 6 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06422143

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

Mengambil pesertaFasa 2
  • Lehigh Valley Health Network (Data Collection Only), Allentown
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Mei 2026 · NCT05657873

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Mengambil pesertaKajian pemerhatian
  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem · 6 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Mengambil pesertaFasa 2
  • Lehigh Valley Health Network, Allentown
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Feb 2026 · NCT03808337

Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain

Kajian lain di Allentown

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.